Molecular fingerprinting reveals familial transmission of rifampin-resistant tuberculosis in Kuwait

Annals of Saudi Medicine

Volumn 25, Issue 2, 2005, Pages 150-153

  Mokaddas, Eiman ^a   Ahmad, Suhail ^a   Abal, Adnan T ^a   Al Shami, Abdul S ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Chest Diseases Hospital Kuwait   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ABSCESS; ADULT; ANOREXIA; ANTIBIOTIC RESISTANCE; ARTICLE; ASPIRATION BIOPSY; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CASE REPORT; COUGHING; DNA FINGERPRINTING; DNA SEQUENCE; FEMALE; FEVER; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KUWAIT; LUNG INFILTRATE; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUBERCULOSIS CONTROL; WEIGHT REDUCTION;

EID: 18744402242     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2005.150     Document Type: Article

References (23)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-899.
2. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis. 2002;185:1197-1202.
3. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 1998;79:3-29.
4. Frieden, TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooleyl SW. The emergence of drug-resistant tuberculosis in NY City. N Engl J Med. 1993;328:521-526.
5. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994;330:1703-1709.
6. Sofia M, Maniscalco M, Honore N, Molino A, Mormile M, Heym B, Cole ST. Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis. Int J Tuberc Lung Dis. 2001; 5:551-558.
7. Dahle UR, Sandven P, Heldal E, Mannsaaker T, Caugant DA. Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2003;41:67-72.
8. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330: 710-1716.
9. Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreisworth BN, Mildvan D. Predictors and outcome of multidrug-resistant tuberculosis. Clin Infect Dis. 1995;21:1245-1252.
10. Nolan CM, Williams DL, Cave MD, Eisenach KD, El-Hajj H, Hooton TM, Thompson RL, Goldberg SV. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med. 1995;152:1067-1071.
11. Ahmad S, Araj GF, Akbar PK, Fares E, Chugh TD, Mustafa AS. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diag Microbiol Infect Dis. 2000;38:227-232.
12. Ahmad S, Mokaddas E, Fares E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai. Diag Microbiol Infect Dis. 2002; 44:245-252.
13. Ahmad S, Mokaddas E, Jaber A.-A. Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. Mol Cell Probes. 2004;18:299-306.
14. Mokaddas E, Ahmad S, and Abal AT. Molecular fingerprinting of isoniazid-resistant Mycobacterium tuberculosis isolates from Chest Diseases Hospital in Kuwait. Microbiol Immunol. 2002;46:767-771.
15. Sreevatsan S, Pan X, Stockbauer KE et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc Natl Acad Sci. USA 1997;94:9869-9874.
16. Ahmad S, Abal AT, Mokaddas E, Araj GF, Fares E, Mustafa AS. Genetic polymorphism at codon 463 in the katG gene in isoniazid-sensitive and -resistant isolates of Mycobacterium tuberculosis from the Middle East. Med Princ Pract. 2001; 10: 129-134.
17. Behbehani N, Abal A, Al-Shami A, Enarson DA. Epidemiology of tuberculosis in Kuwait from 1965 to 1999. Int J Tuberc Lung Dis. 2002;6:465-469.
18. Abal AT, Ahmad S, Mokaddas, E. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Microb Drug Resist. 2002;8:99-105.
19. Ahmad S, Mokaddas, E. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from the Middle East. Int J Antimicrob Agents. 2004;23:473-479.
20. Kiepiela P, Bishop K, Kormuth E, Roux L, York DF. Comparison of PCR-heteroduplex characterization by automated DNA sequencing and line probe assay for the detection of rifampin resistance in Mycobacterium tuberculosis isolates from KwaZulu-Natal, South Africa. Microb Drug Resist. 1998;4:263-269.
21. Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999;37:2663-2666.
22. Kimerling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest 1998;113:1178-1183.
23. Morehead RS. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels. South Med J. 2000;93:507-510.